Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer
Status:
Terminated
Trial end date:
2000-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Diagnostic procedures, such as blue dye or imaging to identify sentinel lymph
nodes, may improve the ability to detect the extent of disease and help plan effective
surgery for removing breast tumors.
PURPOSE: Diagnostic trial to study the effectiveness of blue dye and an imaging procedure to
identify the sentinel lymph node under the arm in women with stage I or stage II breast
cancer.